A Non-CME Educational Program during the 2025 AAAAI/WAO Joint Congress: Expert Panel Discussion Featuring a Patient

Program Overview

Hereditary angioedema (HAE) is a rare disease that causes painful, unpredictable, and potentially life-threatening episodes of subcutaneous or mucosal swelling. Attacks can be a source of stress, anxiety, and may interfere with a person’s ability to live a normal life. In this activity, a patient-provider panel sheds light on the challenges of living with HAE and the promise emerging therapies hold for this patient population.

*This program is not certified for continuing education credit.

Expires: March 3, 2025

Target Audience

Allergists/clinical immunologists, primary care, and pediatric clinicians

Educational Objectives

Upon completion of this activity, participants should be better able to:

Describe the burden of hereditary angioedema (HAE) and the resulting multifaceted effects that it has on patients’ lives
Integrate objective tools for assessing quality-of-life in patients with HAE into clinical practice
Assess the ways novel HAE on-demand and prophylactic therapies may reduce the burden of treatment
Develop individualized HAE treatment plans that result in improved health outcomes and normalization of life

Activity Faculty

Marc A. Riedl, MD, MS

Professor, Medicine
Clinical Director, US HAEA Angioedema Center
Clinical Service Chief and Training Program Director
Division of Rheumatology, Allergy & Immunology
University of California, San Diego
San Diego, CA

William R. Lumry, MD

Clinical Professor, Internal Medicine
University of Texas Southwestern Medical School
Dallas, TX

Supporter Statement

Supported by independent educational grants from Ionis Pharmaceuticals, Inc. and Pharming Healthcare, Inc.

Provider Statement

This educational activity was independently developed by RMEI Medical Education, LLC. All faculty and planner relevant financial relationships were identified and mitigated and RMEI Medical Education, LLC has reviewed the content and determined it to be fair, balanced, and without commercial bias.

Disclosure of Financial Relationships

RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. RMEI will disclose to learners the presence or absence of relevant financial relationships for all persons in control of content before the learner engages in the education.

Faculty

RMEI will disclose to learners the presence or absence of relevant financial relationships for all persons in control of content before the learner engages in the education.

Planners and Managers

RMEI will disclose to learners the presence or absence of relevant financial relationships for all persons in control of content before the learner engages in the education.

Accreditation Statement

This program is not certified for continuing education credit.
The content and opinions expressed are those of the provider and/or presenter(s) and are not necessarily those of the AAAAI.

Method of Participation and Request for Credit

This program is not certified for continuing education credit.
The content and opinions expressed are those of the provider and/or presenter(s) and are not necessarily those of the AAAAI.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 